SCHEMBL9790685

SCHEMBL9790685

CCOP(=O)(OCC)C(Nc1nc(C)cs1)P(=O)(OCC)OCC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.61
MAPT P10636 2/20 0.41
GCK P35557 1/20 0.39
NPC1 O15118 11/20 0.39
KMT2A Q03164 4/20 0.39
RAB9A P51151 11/20 0.39
POLB P06746 2/20 0.39
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
HPGD P15428 2/20 0.37
CASP3 P42574 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
HTT P42858 1/20 0.36
MEN1 O00255 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GAA P10253 2/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9790635 0.76 FDPS (1.00) FDPSMAPTNPC1RAB9APOLB
SCHEMBL9790646 0.75 FDPS (0.97) FDPSMAPTNPC1RAB9APOLB
SCHEMBL9790861 0.75 FDPS (0.58) FDPSMAPTNPC1KMT2ARAB9A
SCHEMBL9790727 0.73 FDPS (0.61) FDPSMAPTNPC1KMT2ARAB9A
SCHEMBL8159160 0.72 FDPS (0.63) FDPSMAPTNPC1KMT2ARAB9A
SCHEMBL12921530 0.71 FDPS (0.53) FDPSMAPTNPC1KMT2ARAB9A
SCHEMBL9790662 0.71 FDPS (0.80) FDPSMAPTNPC1KMT2ARAB9A
SCHEMBL9274997 0.70 HMGCR (0.38) MAPTRAB9APOLBKDM4EALDH1A1
SCHEMBL5359327 0.70 NPC1 (0.52) MAPTNPC1KMT2ARAB9AKDM4E
SCHEMBL2777930 0.68 FDPS (0.58) FDPSMAPTNPC1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5057505-A Treatment of illnesses attributed to calcium metabolism disorders CIBA-GEIGY CORPORATION (US) 1991-10-15 US disclosed